Antisense Therapeutics (ANP)

Stock Code


Stock Exchange


Antisense Therapeutics Limited (ANP) is an Australian-based company operating mainly in the health care industry. Antisense is engaged in the creation, development and commercialisation of the antisense pharmaceuticals. Its principal activity involves utilisation of the antisense technology for the development of therapeutics for human diseases with main operations in Australia, US, Japan and Europe. ANP was listed on the Australian Stock Exchange on the 20th of December 2001. Its average annual revenue reaches approximately AUD$486 thousand out of its issued capital of $39 million.

Antisense Therapeutics Dividends

18 October, 2010 - 01:06

Research the historical dividends for Antisense Therapeutics. Dividends are a portion of company profits paid out to shareholders. If Antisense Therapeutics Limited has announced a dividend, you may be eligible to receive ANP dividends if the stock trader the company's shares on the ex-dividend date. In order to receive the dividend payout, investors must purchase the shares before the ex dividend date. The previous owner of the shares will receive the dividend if you buy the stocks on or after the ex dividend date.

Syndicate content

Recommended Websites